Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Open accessThe DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Abstract
The same genetic variant found in different individuals can cause a range of diverse phenotypes, from no discernible clinical phenotype to severe disease, even among related individuals. Such variants can be said to display incomplete penetrance, a binary phenomenon where the genotype either causes the expected clinical phenotype or it does not, or they can be said to display variable expressivity, in which the same genotype can cause a wide range of clinical symptoms across a spectrum. Both incomplete penetrance and variable expressivity are thought to be caused by a range of factors, including common variants, variants in regulatory regions, epigenetics, environmental factors, and lifestyle. Many thousands of genetic variants have been identified as the cause of monogenic disorders, mostly determined through small clinical studies, and thus, the penetrance and expressivity of these variants may be overestimated when compared to their effect on the general population. With the wealth of population cohort data currently available, the penetrance and expressivity of such genetic variants can be investigated across a much wider contingent, potentially helping to reclassify variants that were previously thought to be completely penetrant. Research into the penetrance and expressivity of such genetic variants is important for clinical classification, both for determining causative mechanisms of disease in the affected population and for providing accurate risk information through genetic counseling. A genotype-based definition of the causes of rare diseases incorporating information from population cohorts and clinical studies is critical for our understanding of incomplete penetrance and variable expressivity. This review examines our current knowledge of the penetrance and expressivity of genetic variants in rare disease and across populations, as well as looking into the potential causes of the variation seen, including genetic modifiers, mosaicism, and polygenic factors, among others. We also considered the challenges that come with investigating penetrance and expressivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–331 of 331
Kim, E., Напиерала, М., & Dent, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr542 · Cited by 94
Netherton Syndrome: A Genotype-Phenotype Review
Sarri, C. A., Roussaki‐Schulze, A., Vasilopoulos, Y., Zafiriou, E., Patsatsi, A., Stamatis, C., Gidarokosta, P., Sotiriadis, D., Sarafidou, T., & Mamuris, Z. (2016) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0243-y · Cited by 94
Wright, C. F., Prigmore, E., Rajan, D., Handsaker, J., McRae, J. F., Kaplanis, J., Fitzgerald, T. W., FitzPatrick, D. R., Firth, H. V., & Hurles, M. E. (2019) · Nature Communications · doi:10.1038/s41467-019-11059-2 · Cited by 94
Self-citationMorales, F., Vásquez, M., Santamaría, C., Cuenca, P., Corrales, E., & Monckton, D. G. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.01.001 · Cited by 92
Predicting genetic modifier loci using functional gene networks
Lee, I., Lehner, B., Vavouri, T., Shin, J., Fraser, A. G., & Marcotte, E. M. (2010) · Genome Research · doi:10.1101/gr.102749.109 · Cited by 91
Buglo, E., Sarmiento, E., Martuscelli, N. B., Sant, D., Danzi, M. C., Abrams, A. J., Dallman, J. E., & Zuchner, S. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230566 · Cited by 90
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases
Mensa‐Vilaró, A., García‐Morato, M. B., Calle-Martin, O. D. L., Franco‐Jarava, C., Martínez-Saavedra, M. T., González‐Granado, L. I., González‐Roca, E., Fuster, J. L., Alsina, L., Mutchinick, O. M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.09.009 · Cited by 89
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype
Jing, H., Zhang, Q., Zhang, Y., Hill, B. J., Dove, C. G., Gelfand, E. W., Atkinson, T. P., Uzel, G., Matthews, H. F., Mustillo, P., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.025 · Cited by 86
Bae, H. T., Baldwin, C. T., Paola Sebastiani, B., Telen, M. J., Ashley‐Koch, A. E., Garrett, M. E., Hooper, W. C., Bean, C. J., DeBaun, M. R., Arking, D. E., et al. (2012) · Blood · doi:10.1182/blood-2012-06-432849 · Cited by 84
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease
Hopp, K., Gall, É. C.-L., Senum, S. R., Paske, I. T., Raj, S., Lavu, S., Baheti, S., Edwards, M. E., Madsen, C. D., Heyer, C. M., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.08.038 · Cited by 84
Chami, N., Preuss, M., Walker, R. W., Moscati, A., & Loos, R. J. F. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003196 · Cited by 84
Wright, C. F., Quaife, N. M., Ramos-Hernández, L., Danecek, P., Ferla, M. P., Samocha, K. E., Kaplanis, J., Gardner, E. J., Eberhardt, R. Y., Chao, K. R., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.025 · Cited by 83
Self-citationWojcik, M. H., Zhang, T., Ceyhan‐Birsoy, O., Genetti, C. A., Lebo, M. S., Yu, T. W., Parad, R. B., Holm, I. A., Rehm, H. L., Beggs, A. H., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01146-5 · Cited by 82
Genetic disorders of the surfactant system: focus on adult disease
van Moorsel, C. H. M., van der Vis, J. J., & Grutters, J. C. (2021) · European Respiratory Review · doi:10.1183/16000617.0085-2020 · Cited by 81
Lung disease modifier genes in cystic fibrosis
Guillot, L., Beucher, J., Tabary, O., Rouzic, P. L., Clément, A., & Corvol, H. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.02.011 · Cited by 80
Hereditary angioedema: Molecular and clinical differences among European populations
Speletas, M. G., Szilágyi, Á., Psarros, F., Moldovan, D., Magerl, M. A. K., Kompoti, M., Gramoustianou, E., Bors, A., Mihály, E., Tordai, A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.007 · Cited by 78
Chen, R., Morgan, A. A., Dudley, J. T., Deshpande, T., Li, L., Kodama, K., Chiang, A. P.-F., & Butte, A. J. (2008) · Genome biology · doi:10.1186/gb-2008-9-12-r170 · Cited by 78
23andMe: a new two-sided data-banking market model
Stoeklé, H., Mamzer, M., Vogt, G., & Hervé, C. (2016) · BMC Medical Ethics · doi:10.1186/s12910-016-0101-9 · Cited by 78
Disrupting upstream translation in mRNAs is associated with human disease
Lee, D. S. M., Park, J., Kromer, A., Baras, A., Rader, D. J., Ritchie, M. D., Ghanem, L. R., & Barash, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-21812-1 · Cited by 78
Magri, S., Nanetti, L., Gellera, C., Sarto, E., Rizzo, E., Mongelli, A., Ricci, B., Fancellu, R., Sambati, L., Cortelli, P., et al. (2021) · Genetics in Medicine · doi:10.1016/j.gim.2021.08.003 · Cited by 77
Zernant, J., Lee, W., Nagasaki, T., Collison, F. T., Fishman, G. A., Bertelsen, M., Rosenberg, T., Gouras, P., Tsang, S. H., & Allikmets, R. L. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002733 · Cited by 76
The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele
Aubart, M., Gross, M., Hanna, N., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv037 · Cited by 74
Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders
Holmans, P., Massey, T. H., & Jones, L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx261 · Cited by 74
Tarailo-Graovac, M., Zhu, J. Y. A., Matthews, A., van Karnebeek, C. D. M., & Wasserman, W. W. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.50 · Cited by 73
Zhang, X., Walsh, R., Whiffin, N., Buchan, R. J., Midwinter, W., Wilk, A., Govind, R., Li, N., Ahmad, M., Mazzarotto, F., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-00972-3 · Cited by 73
Human Monogenic Disease Genes Have Frequently Functionally Redundant Paralogs
Chen, W., Zhao, X., van Noort, V., & Bork, P. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003073 · Cited by 72
Variant haploinsufficiency and phenotypic non‐penetrance in PRPF31 ‐associated retinitis pigmentosa
Rose, A. M., & Bhattacharya, S. S. (2016) · Clinical Genetics · doi:10.1111/cge.12758 · Cited by 72
Ribosome Elongation Stall Directs Gene-specific Translation in the Integrated Stress Response
Young-Baird, S. K., Palam, L. R., Wu, C., Sachs, M. S., & Wek, R. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705640 · Cited by 71
Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review
Fink, D. A., Nelson, L. M., Pyeritz, R. E., Johnson, J., Sherman, S. L., Cohen, Y., & Elizur, S. E. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00529 · Cited by 71
Protein Misfolding and Endoplasmic Reticulum Stress in Chronic Lung Disease
Wei, J., Rahman, S., Ayaub, E. A., Dickhout, J. G., & Ask, K. (2013) · CHEST Journal · doi:10.1378/chest.12-2133 · Cited by 70
A monozygotic twin pair with highly discordant Gaucher phenotypes
Biegstraaten, M., van Schaik, I. N., Aerts, J. M. F. G., Langeveld, M., Mannens, M. M. A. M., Bour, L. J., Sidransky, E., Tayebi, N., Fitzgibbon, E. J., & Hollak, C. E. M. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.10.007 · Cited by 70
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy
Glazier, A. A., Thompson, A. D., & Day, S. M. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2226-9 · Cited by 70
The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene
Torella, A., Zanobio, M., Zeuli, R., Blanco, F. D. V., Savarese, M., Giugliano, T., Garofalo, A., Piluso, G., Politano, L., & Nigro, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237803 · Cited by 70
Variable expression of neurofibromatosis 1 in monozygotic twins
Rieley, M. B., Stevenson, D. A., Viskochil, D. H., Tinkle, B. T., Martin, L. J., & Schorry, E. K. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33851 · Cited by 69
Pereira, S. V.-N., Ribeiro, J. D., Ribeiro, A. F., Bertuzzo, C. S., & Marson, F. A. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-42404-6 · Cited by 69
What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
Neeve, V. C. M., Samuels, D. C., Bindoff, L. A., van den Bosch, B. J. C., Goethem, G. V., Smeets, H. J. M., Lombès, A., Jardel, C., Hirano, M., DiMauro, S., et al. (2012) · Brain · doi:10.1093/brain/aws298 · Cited by 68
Individualized Iterative Phenotyping for Genome-wide Analysis of Loss-of-Function Mutations
Johnston, J. J., Lewis, K. L., Ng, D., Singh, L. N., Wynter, J., Brewer, C., Brooks, B. P., Brownell, I., Candotti, F., Gonsalves, S. G., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.013 · Cited by 67
Zhang, L. X., Lemire, G., Gonzaga-Jauregui, C. G., Molidperee, S., Galaz-Montoya, C. I., Liu, D. S., Verloès, A., Shillington, A., Izumi, K., Ritter, A. L., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0811-8 · Cited by 65
Kingdom, R., Tuke, M. A., Wood, A. R., Beaumont, R. N., Frayling, T. M., Weedon, M. N., & Wright, C. F. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.05.011 · Cited by 65
Self-citationUncovering Missing Heritability in Rare Diseases
Maroilley, T., & Tarailo‐Graovac, M. (2019) · Genes · doi:10.3390/genes10040275 · Cited by 64
Nutrition Management of Cystic Fibrosis in the 21st Century
Schindler, T., Michel, S. H., & Wilson, A. W. M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615591604 · Cited by 63
Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2
Kolder, I. C. R. M., Tanck, M. W. T., Postema, P. G., Barc, J., Sinner, M. F., Zumhagen, S., Husemann, A., Stallmeyer, B., Koopmann, T. T., Hofman, N., et al. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000785 · Cited by 63
Challenges in Clinicogenetic Correlations: One Gene – Many Phenotypes
Magrinelli, F., Balint, B., & Bhatia, K. P. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13165 · Cited by 63
Miller, E. E., Kobayashi, G. S., Musso, C. M., Allen, M., Ishiy, F. A. A., de Caires, L. C., Goulart, E., Griesi‐Oliveira, K., Zechi‐Ceide, R. M., Richieri‐Costa, A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx078 · Cited by 62
Reduced penetrance in human inherited disease
Shawky, R. M. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2014.01.003 · Cited by 61
When genetic burden reaches threshold
Walsh, R., Tadros, R., & Bezzina, C. R. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa269 · Cited by 60
Chromatin Conformation in Development and Disease
Boltsis, I., Grosveld, F. G., Giraud, G., & Kolovos, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.723859 · Cited by 60
Allelic Expression Imbalance Promoting a Mutant PEX6 Allele Causes Zellweger Spectrum Disorder
Falkenberg, K. D., Braverman, N., Moser, A. B., Steinberg, S. J., Klouwer, F. C. C., Schlüter, A., Ruíz, M., Pujol, A., Engvall, M., Naess, K., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.11.007 · Cited by 57
Akinrinade, O., Heliö, T. M., Deprez, R. H. L., Jongbloed, J. D. H., Boven, L. G., van den Berg, M. P., Pinto, Y. M., Alastalo, T., Myllykangas, S., van Spaendonck‐Zwarts, K. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39911-x · Cited by 57
Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes
Kumar, K. R., Davis, R. L., Tchan, M. C., et al. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.004 · Cited by 57
Nicoletti, E., Rao, G. R., Bueren, J. A., Río, P., Navarro, S., Surrallés, J., Choi, G., & Schwartz, J. D. (2020) · Annals of Hematology · doi:10.1007/s00277-020-03954-2 · Cited by 57
Influence of family history on penetrance of hereditary cancers in a population setting
Jackson, L. M., Weedon, M. N., Green, H., Mallabar-Rimmer, B., Harrison, J., Wood, A. R., Ruth, K., Tyrrell, J., & Wright, C. F. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102159 · Cited by 57
Self-citationDeregulated Regulators: Disease-Causing cis Variants in Transcription Factor Genes
van der Lee, R., Correard, S., & Wasserman, W. W. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.04.006 · Cited by 56
Pasmooij, A. M. G., García, M., Escamez, M. J., Nijenhuis, A. M., Azón, A., Cuadrado‐Corrales, N., Jonkman, M. F., & Río, M. D. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.163 · Cited by 55
Implication of LRRC4C and DPP6 in neurodevelopmental disorders
Maussion, G., Cruceanu, C., Rosenfeld, J. A., Bell, S. C., Jollant, F., Szatkiewicz, J., Collins, R. L., Hanscom, C., Kolobova, I., de Champfleur, N. M., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38021 · Cited by 55
Translational Regulation by Upstream Open Reading Frames and Human Diseases
Silva, J., Fernandes, R. O., & Romão, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-19966-1_5 · Cited by 54
Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency
Heusinkveld, L. E., Yim, E., Yang, A. Y., Azani, A. B., Liu, Q., Gao, J., McDermott, D. H., & Murphy, P. M. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1375403 · Cited by 53
Lee, W., Zernant, J., Nagasaki, T., Molday, L. L., Su, P.-Y., Fishman, G. A., Tsang, S. H., Molday, R. S., & Allikmets, R. L. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab122 · Cited by 53
Allelic Imbalance Is a Prevalent and Tissue-Specific Feature of the Mouse Transcriptome
Pinter, S. F., Colognori, D., Beliveau, B. J., Sadreyev, R. I., Payer, B., Yildirim, E., Wu, C.-T., & Lee, J. T. (2015) · Genetics · doi:10.1534/genetics.115.176263 · Cited by 51
Mechanisms of suppression: The wiring of genetic resilience
van Leeuwen, J. S., Pons, C., Boone, C. M., & Andrews, B. (2017) · BioEssays · doi:10.1002/bies.201700042 · Cited by 51
Interstitial lung diseases in children
Nathan, N., Berdah, L., Delestrain, C., Siléo, C., & Clément, A. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2019.06.007 · Cited by 49
The roles of iron and HFE genotype in neurological diseases
Kim, Y., & Connor, J. R. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100867 · Cited by 48
van Rooij, J., Arp, P., Broer, L., Verlouw, J., van Rooij, F. J. A., Kraaij, R., Uitterlinden, A. G., & Verkerk, A. J. M. H. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0900-8 · Cited by 46
Fetit, R., Price, D. J., Lawrie, S. M., & Johnstone, M. (2020) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000259 · Cited by 46
Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression
Hesson, L. B., Packham, D., Kwok, C., Nunez, A. C., Ng, B., Schmidt, C., Fields, M., Wong, J. W. H., Sloane, M. A., & Ward, R. L. (2015) · Human Mutation · doi:10.1002/humu.22785 · Cited by 44
Landscape of Pleiotropic Proteins Causing Human Disease: Structural and System Biology Insights
Ittisoponpisan, S., Alhuzimi, E. M., Sternberg, M. J. E., & David, A. (2016) · Human Mutation · doi:10.1002/humu.23155 · Cited by 42
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features
Bertolini, S., Calandra, S., Arca, M., Averna, M. R., Catapano, A. L., Tarugi, P., Bartuli, A., Bucci, M., Buonuomo, P. S., Calabrò, P., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.027 · Cited by 42
Bozhilov, Y. K., Downes, D. J., Telenius, J. M., Oudelaar, A. M., Olivier, E. N., Mountford, J. C., Hughes, J. R., Gibbons, R. J., & Higgs, D. R. (2021) · Nature Communications · doi:10.1038/s41467-021-23980-6 · Cited by 39
CCG•CGG interruptions in high‐penetrance SCA8 families increase RAN translation and protein toxicity
Perez, B. A., Shorrock, H. K., Báñez-Coronel, M., Zu, T., Romano, L. E. L., Laboissonniere, L. A., Reid, T. S., Ikeda, Y., Reddy, K., Gomez, C. M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114095 · Cited by 39
Understanding redundancy and resilience
Hunter, P. (2022) · EMBO Reports · doi:10.15252/embr.202254742 · Cited by 39
Genetics meets DNA methylation in rare diseases
Velasco, G., & Francastel, C. (2018) · Clinical Genetics · doi:10.1111/cge.13480 · Cited by 38
Human gene expression variability and its dependence on methylation and aging
Bashkeel, N., Perkins, T. J., Kærn, M., & Lee, J. M. (2019) · BMC Genomics · doi:10.1186/s12864-019-6308-7 · Cited by 38
Olszewski, A. K., Radoeva, P. D., Fremont, W., Kates, W. R., & Antshel, K. M. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.08.034 · Cited by 37
Klaassen, P., Duijff, S. N., de Veye, H. F. N. S., Beemer, F. A., Sinnema, G., Breetvelt, E., Schappin, R., & Vorstman, J. A. S. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32441 · Cited by 37
Beyond the simplicity of Mendelian inheritance
Schacherer, J. (2016) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2016.04.006 · Cited by 37
Genetic modifiers of long‐term survival in sickle cell anemia
Wonkam, A., Chimusa, E. R., Mnika, K., Pule, G. D., Bitoungui, V. J. N., Mulder, N., Shriner, D., Rotimi, C. N., & Adeyemo, A. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.152 · Cited by 37
Park, J. K., Martin, L. J., Zhang, X., Jegga, A. G., & Benson, D. W. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.02.023 · Cited by 36
Reversion Mosaicism in Primary Immunodeficiency Diseases
Miyazawa, H., & Wada, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783022 · Cited by 36
Cárdenas-Rodríguez, M., Osborn, D. P. S., Irigoín, F., Graña, M., Romero, H., Beales, P. L., & Badano, J. L. (2012) · Human Genetics · doi:10.1007/s00439-012-1228-5 · Cited by 35
Natural variants suppress mutations in hundreds of essential genes
Parts, L., Batté, A., Lopes, M., Yuen, M. W.-K., Laver, M., Luis, B.-J. S., Yue, J., Pons, C., Eray, E., Aloy, P., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010138 · Cited by 35
GRIN2A Variants Associated With Idiopathic Generalized Epilepsies
Liu, X., Xu, X., Lin, S., Fan, C.-Y., Ye, T.-T., Tang, B., Shi, Y., Su, T., Li, B.-M., Yi, Y., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.720984 · Cited by 35
Sarkar, H., Mitsios, A., Smart, M. J. K., Skinner, J. S., Welch, A. A., Kalatzis, V., Coffey, P. J., Dubis, A. M., Webster, A. R., & Moosajee, M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz028 · Cited by 34
Incomplete penetrance and variable expressivity: is there a microRNA connection?
Ahluwalia, J. K., Hariharan, M., Bargaje, R., Pillai, B., & Brahmachari, V. (2009) · BioEssays · doi:10.1002/bies.200900066 · Cited by 33
Domogala, D., Gambin, T., Zemet, R., Wu, C. W., Schulze, K., Yang, Y., Wilson, T. A., Machol, I., Liu, P., & Stankiewicz, P. (2021) · Human Genomics · doi:10.1186/s40246-021-00369-6 · Cited by 33
Galupa, R., & Heard, É. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.035030 · Cited by 32
Senol-Cosar, O., Schmidt, R. J., Qian, E., Hoskinson, D. C., Mason‐Suares, H., Funke, B., & Lebo, M. S. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0560-8 · Cited by 32
Genetic modifiers of severity in sickle cell disease
Chang, A. K., Summarell, C. C. G., Birdie, P. T., & Sheehan, V. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189004 · Cited by 31
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals
Lacaze, P. A., Sebra, R., Riaz, M., Tiller, J. M., Revote, J., Phung, J., Parker, E. J., Orchard, S. G., Lockery, J. E., Wolfe, R. S., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0881-7 · Cited by 31
Pathogenic EFHC 1 mutations are tolerated in healthy individuals dependent on reported ancestry
Subaran, R. L., Conte, J. M., Stewart, W. C. L., & Greenberg, D. A. (2014) · Epilepsia · doi:10.1111/epi.12864 · Cited by 30
Kharbanda, M., Kannike, K., Lampe, A., Berg, J., Timmusk, T., & Sepp, M. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.04.003 · Cited by 30
Hanany, M., & Sharon, D. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105971 · Cited by 29
The Impact of Environmental Factors on Monogenic Mendelian Diseases
Tukker, A. M., Royal, C. D. M., Bowman, A. B., & McAllister, K. A. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab022 · Cited by 29
Human Diseases from Gain-of-Function Mutations in Disordered Protein Regions
Li, X., & Babu, M. M. (2018) · Cell · doi:10.1016/j.cell.2018.08.059 · Cited by 28
Elfatih, A., Mohammed, I., Abdelrahman, D., & Mifsud, B. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00025.2021 · Cited by 28
Servetti, M., Pisciotta, L., Tassano, E., Cerminara, M., Nobili, L., Boeri, S., Rosti, G., Lerone, M., Divizia, M. T., Ronchetto, P., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.732002 · Cited by 28
Monogenic and Polygenic Models of Coronary Artery Disease
Muse, E. D., Chen, S.-F., & Torkamani, A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01540-0 · Cited by 27
Hammer, M. F., Ishii, A., Johnstone, L. M., Tchourbanov, A. Y., Lau, B., Sprissler, R. S., Hallmark, B., Zhang, M., Zhou, J. J., Watkins, J. C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180485 · Cited by 27
Gui, B., Slone, J. D., & Huang, T. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00191 · Cited by 27
Diverse Genome Topologies Characterize Dosage Compensation across Species
Jordan, W. T., Rieder, L. E., & Larschan, E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.02.001 · Cited by 26
Epigenetics and genomics in Klinefelter syndrome
Skakkebaek, A. H., Viuff, M. H., Nielsen, M. M., & Gravholt, C. H. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31802 · Cited by 26
Kishore, S., Franco, E. D., Cardenas‐Diaz, F. L., Letourneau, L. R., Sanyoura, M., Osorio-Quintero, C., French, D. L., Greeley, S. A. W., Hattersley, A. T., & Gadue, P. J. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.05.001 · Cited by 25
Allard, P., Alhaj, N., Lobitz, S., Cario, H., Jarisch, A., Grosse, R., Oevermann, L., Hakimeh, D., Tagliaferri, L., KOHNE, E., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278952 · Cited by 24
The search for modifier genes in Huntington disease – Multifactorial aspects of a monogenic disorder
Arning, L. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.06.006 · Cited by 23
Gene–environment interactions in primary atopic disorders
Sacco, K. A., & Milner, J. D. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.06.002 · Cited by 22
Nuclear mRNA Quality Control and Cytoplasmic NMD Are Linked by the Guard Proteins Gbp2 and Hrb1
Lu, Y.-Y., & Krebber, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011275 · Cited by 22
Sirp, A., Roots, K., Nurm, K., Tuvikene, J., Sepp, M., & Timmusk, T. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101381 · Cited by 22
Evans, D. W., & Uljarević, M. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38519 · Cited by 21
Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
Stephanou, C., Tamana, S., Minaidou, A., Papasavva, P. L., Kleanthous, M., & Kountouris, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111927 · Cited by 21
Goula, A.-V., & Mérienne, K. (2013) · Genes · doi:10.3390/genes4030375 · Cited by 19
Ibrahim, D. M., Tayebi, N., Knaus, A., Stiege, A. C., Sahebzamani, A., Hecht, J., Mundlos, S., & Spielmann, M. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37464 · Cited by 19
Variability in Gene Expression is Associated with Incomplete Penetrance in Inherited Eye Disorders
Green, D. J., Sallah, S. R., Ellingford, J., Lovell, S., & Sergouniotis, P. (2020) · bioRxiv · doi:10.3390/genes11020179 · Cited by 19
Pediatric writer's cramp in myoclonus-dystonia: Maternal imprinting hides positive family history
Gerrits, M. C. F., Foncke, E. M. J., Koelman, J. H. T. M., & Tijssen, M. A. J. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.03.007 · Cited by 18
Downs, B. M., Sherman, S., Cui, J., Kim, Y. C., Snyder, C., Christensen, M., Luo, J., Lynch, H. T., & Wang, S. M. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.10.022 · Cited by 18
Pipis, M., Cortese, A., Polke, J. M., Poh, R., Vandrovcová, J., Laurá, M., Skorupinska, M., Jacquier, A., Morales, R. J., Latour, P., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327186 · Cited by 18
Genetic modifiers in rare disorders: the case of fragile X syndrome
Crawford, H., Scerif, G., Wilde, L., Beggs, A. D., Stockton, J., Sandhu, P., Shelley, L., Oliver, C., & McCleery, J. P. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00711-x · Cited by 17
Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier
Klaassen, K., Djordjevic, M., Skakić, A., Kecman, B., Drmanac, R., Pavlović, S., & Stojiljković, M. (2021) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2021.100822 · Cited by 17
Taniguchi, Y., Takeda, N., Inuzuka, R., Matsubayashi, Y., Kato, S., Doi, T., Yagi, H., Yamauchi, H., Ando, M., Oshima, Y., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-108186 · Cited by 17
Evidence for penetrance in patients without a family history of disease: a systematic review
Turner, H., & Jackson, L. M. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-019-0556-5 · Cited by 16
A mild form of Stickler syndrome type II caused by mosaicism of COL11A1
Lauritsen, K. F., Lildballe, D. L., Coucke, P. J., Monrad, R., Larsen, D. A., & Gregersen, P. A. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.03.005 · Cited by 14
Vasilyev, S. А., Skryabin, N. A., Кашеварова, А. А., Tolmacheva, E. N., Savchenko, R. R., Vasilyeva, O. Y., Лопаткина, М. Е., Зарубин, А. А., Fishman, V., Belyaeva, E. O., et al. (2021) · Cytogenetic and Genome Research · doi:10.1159/000514491 · Cited by 14
DCTN 4 as a modifier of chronic P seudomonas aeruginosa infection in cystic fibrosis
Viel, M., Hubert, D., Burgel, P., Génin, E., Honoré, I., Martinez, B., Gaitch, N., Chapron, J., Kanaan, R., Dusser, D. J., et al. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12288 · Cited by 13
Payán‐Gómez, C., Ramírez‐Cheyne, J., & Saldarriaga, W. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s265835 · Cited by 13
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers
Tommasi, C., Pellegrino, B., Boggiani, D., Sikokis, A., Michiara, M., Uliana, V., Bortesi, B., Bonatti, F., Mozzoni, P., Pinelli, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700853 · Cited by 12
Incomplete penetrance: The role of stochasticity in developmental cell colonization
Binder, B. J., Landman, K. A., Newgreen, D. F., & Ross, J. V. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.05.028 · Cited by 11
Genomic Sequencing Expansion and Incomplete Penetrance
Shieh, J. T. C. (2019) · PEDIATRICS · doi:10.1542/peds.2018-1099e · Cited by 10
Arora, V., Bijarnia‐Mahay, S., Tiwari, V., Bansal, S., Gupta, P., Setia, N., Puri, R. D., & Verma, I. C. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103734 · Cited by 10
Brachydactyly type A3 is caused by a novel 13 bp HOXD13 frameshift deletion in a Chinese family
Zhang, M., Lu, L., Wei, B. K., Zhang, Y., Li, X., Shi, Y., Ge, W., & Sun, M. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61788 · Cited by 10
Genetic basis of a spontaneous mutation’s expressivity
Schell, R., Hale, J. J., Mullis, M. N., Matsui, T., Foree, R., & Ehrenreich, I. M. (2022) · Genetics · doi:10.1093/genetics/iyac013 · Cited by 9
Laskaratos, A., Breza, M., Karadima, G., & Koutsis, G. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-106963 · Cited by 9
Herve, B., Roume, J., Cognard, S., Fauvert, D., Molina‐Gomes, D., & Vialard, F. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.04.005 · Cited by 7
Hassanin, E., May, P., Aldisi, R. S., Krawitz, P. M., Maj, C., & Bobbili, D. R. (2021) · medRxiv · doi:10.1101/2021.06.06.21253270 · Cited by 4
Cited by
Schubach, M., Maass, T., Nazaretyan, L., Röner, S., & Kircher, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad989 · Cited by 455
QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction
Maharaj, A. V., Ishida, M., Rybak, A., Elfeky, R., Andrews, A., Joshi, A., Elmslie, F., Joensuu, A., Kantojärvi, K., Jia, R. Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52587-w · Cited by 9
Jenkins, D. (2024) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2023.0045 · Cited by 6
Metadata
- Authors
- Kingdom, R., & Wright, C. F.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2022-07-25
- Volume
- 13
- Pages
- 920390-920390
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W4287218243
- Cited by
- 287
- References
- 331
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.